Resencatinib
Resencatinib is a potent tyrosine kinase inhibitor with antineoplastic activity[1]. Resencatinib is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Product Specifications
CAS Number
2546117-79-5
UNSPSC
12352005
Target
C-Met/HGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/resencatinib.html
Solubility
10 mM in DMSO
Smiles
N#CC1=C2C(C3=CN=C(N(CC4C5)CC5N4CC(C=C6)=CN=C6OC)C=C3)=CC(OC[C@](C)(O)C#C)=CN2N=C1
Molecular Formula
C30H29N7O3
Molecular Weight
535.60
References & Citations
[1]WHO Drug Information-World Health Organization (WHO) .
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
